Summary of Sepsis-induced cardiac dysfunction: mitochondria and energy metabolism (Yu et al.)
Abstract Summary: Yu et al. systematically reviewed the pathophysiological mechanisms underlying sepsis-induced myocardial dysfunction (SIMD), emphasizing mitochondrial dysfunction and disruptions in myocardial energy metabolism. The review highlights critical aspects, including alterations in myocardial substrates, mitochondrial damage, oxidative stress, calcium imbalance, mitochondrial DNA (mtDNA) metabolism, and mitochondrial autophagy and biogenesis. The authors also discussed potential therapeutic targets that could improve clinical outcomes in SIMD.
Key Points:
-
Clinical Significance of SIMD: SIMD significantly increases mortality in septic patients, characterized by mitochondrial dysfunction and disrupted myocardial energy metabolism rather than cardiomyocyte apoptosis.
-
Myocardial Energy Metabolism Alterations: In SIMD, impaired fatty acid oxidation, insulin resistance, reduced glucose utilization, and increased lactate uptake occur, highlighting the myocardium’s struggle to adapt energetically under septic conditions.
-
Central Role of Mitochondria: Mitochondria are central to cardiac energy metabolism, calcium homeostasis, and reactive oxygen species (ROS) regulation; mitochondrial damage during sepsis profoundly affects myocardial function.
-
Oxidative Stress Mechanisms: Increased production of ROS, primarily from NADPH oxidases and mitochondrial respiratory complexes, exacerbates mitochondrial dysfunction, contributing significantly to myocardial injury.
-
Impact of Nitric Oxide (NO): Elevated NO levels due to inducible nitric oxide synthase (iNOS) activation worsen mitochondrial dysfunction by inhibiting critical enzymes and respiratory chain components, inducing oxidative and nitrosative stress.
-
Mitochondrial DNA Damage: MtDNA is particularly susceptible to damage during SIMD, exacerbating inflammatory responses through signaling pathways and promoting a cycle of worsening mitochondrial dysfunction.
-
Mitochondrial Calcium Homeostasis: Excessive mitochondrial calcium uptake during sepsis disrupts oxidative phosphorylation, highlighting the importance of calcium regulation as a therapeutic target.
-
Role of Mitophagy and Biogenesis: Proper mitochondrial turnover through autophagy and biogenesis is crucial for maintaining mitochondrial function during sepsis, with disruptions contributing to energy failure.
-
Therapeutic Targets and Strategies: The review identifies promising targets, including antioxidants, mitochondrial protective agents, NO inhibitors, mitochondrial biogenesis and autophagy enhancers, and the reconsideration of lactate as an energy substrate.
-
Novel Therapeutic Approaches: Emerging treatments such as mitochondrial transplantation, metformin, melatonin, and non-coding RNA interventions offer new avenues for therapeutic development against SIMD.
Conclusion: Effective management of SIMD necessitates a deeper understanding of mitochondrial dysfunction and energy metabolism disruptions. Targeting mitochondrial pathways, oxidative stress, and energy substrates presents promising therapeutic strategies to improve outcomes in sepsis-induced myocardial dysfunction.
Watch the following video on “Cardiac Dysfunction in Sepsis” by American Thoracic Society
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
